Associated Papers
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.
López-Oreja I et al.
Hemasphere, 2023
37746159 (PubMed )
Supplement: hs9-7-e962-s002.xlsx › Table_S6
Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity.
Pellegrino E et al.
Bioengineering (basel, Switzerland), 2023
37508780 (PubMed )
Supplement: bioengineering-10-00753-s001.zip › bioengineering-2428084-supplementary.xls › run24012023b_all
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM.
Scala S et al.
Vaccines, 2020
Association of SDF-1 and CXCR4 Polymorphisms With Susceptibility to Oral and Pharyngeal Squamous Cell Carcinoma.
Huang SJ et al.
Anticancer Research, 2019
Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.
Prescott NJ et al.
Plos Genetics, 2015
25671699 (PubMed )
Supplement: pgen.1004955.s006.xlsx › SNVs
Absence of activating mutations of CXCR4 in pituitary tumours.
Lee YH et al.
Clinical Endocrinology, 2010
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia.
Crowther-Swanepoel D et al.
Blood, 2009
Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
Schüller U et al.
International Journal of Cancer, 2005
Select a paper to view details